Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
Molecular therapy. Nucleic acids - 31(2023) vom: 14. März, Seite 437-439 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chakraborty, Chiranjib [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 24.02.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.omtn.2023.01.013 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM353239801 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM353239801 | ||
| 003 | DE-627 | ||
| 005 | 20231226055539.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.omtn.2023.01.013 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1177.xml |
| 035 | |a (DE-627)NLM353239801 | ||
| 035 | |a (NLM)36817724 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chakraborty, Chiranjib |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 24.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a News | |
| 650 | 4 | |a D614G mutation | |
| 650 | 4 | |a Omicron | |
| 650 | 4 | |a natural selection | |
| 650 | 4 | |a subvariant | |
| 700 | 1 | |a Saha, Abinit |e verfasserin |4 aut | |
| 700 | 1 | |a Bhattacharya, Manojit |e verfasserin |4 aut | |
| 700 | 1 | |a Dhama, Kuldeep |e verfasserin |4 aut | |
| 700 | 1 | |a Agoramoorthy, Govindasamy |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular therapy. Nucleic acids |d 2012 |g 31(2023) vom: 14. März, Seite 437-439 |w (DE-627)NLM222953810 |x 2162-2531 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2023 |g day:14 |g month:03 |g pages:437-439 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.omtn.2023.01.013 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2023 |b 14 |c 03 |h 437-439 | ||